Discovering a New Cancer Killer

Dr. Marek Los (2004 Research Grant) 

Marek Los’ research story is classic. While studying the process of cell death he stumbled upon a protein called apoptin which kills cancer cells while sparing healthy cells. Apoptin is sneaky. Cancer cells use certain pathways to keep themselves alive. Apoptin hijacks these pathways and redirects them to kill cancer cells. Even better, apoptin seems to work especially well in hormone refractory prostate cancer – a stage of cancer that is nearly impossible to treat. More research is needed but Los’ work may lead to new treatment options.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More

12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More


Click here for news archive